Copley/Barr verdict
Executive Summary
Massachusetts federal court jury finds that Barr breached an agreement with Copley when it backed out of an 1985 arrangement covering the development of a generic version of Parke-Davis' delayed-release erythromycin product Eryc. In a Nov. 10 verdict, the jury awarded Copley $ 1.2 mil. in damages. A final decision by Judge Douglas Woodlock is expected in December or January. . . .